Makale detayı · 2012 · article
Clinical characteristics treatment and survival outcomes in malignant mesothelioma eighteen years experience in Turkey
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıAsian Pacific Journal of Cancer Prevention
- Katalog eşleşmesi (ISSN)Asian Pacific Journal of Cancer Prevention
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
Özet
BACKGROUND: Malignant mesothelioma (MM) is an insidious tumor with poor prognosis, arising from mesothelial surfaces such as pleura, peritoneum and pericardium. We here aimed to evaluate the demographic, clinical, and radiological features of patients with MM followed in our center as well as their survival. METHODS: The study included 228 patients (131 male, 97 female) who were followed up in our institution between 1993 and 2010 with the diagnosis of MM. RESULTS: The mean age was 59.1 years in men and 58.7 years in women and the sex ratio was 1.4:1 in favor of males. Environmental asbestos exposure was present in 86% of the patients for a mean duration of 40±20 years (range: 3-70). Pleural effusion and thoracic/abdominal pain were the most common presenting signs and symptoms (70.2% and 57.8%, respectively). One hundred-thirteen (66%) patients were treated with platinum-based combination chemotherapy (PBCT) plus supportive care (SC) and 67 (34%) patients received SC alone. The median follow-up time was 10.0 months. The median overall survival was significantly improved with PBCT plus SC compared to SC alone (11.4 vs. 5.1 months; p=0.005). The 6, 12, 18, and 24-month survival rates were significantly improved with PBCT plus SC compared to SC alone (72%, 43%, 19%, and 2% vs. 49%, 31%, 11%, and 1%). CONCLUSION: The survival of patients with MM improved in patients treated with PBCT. The survival advantage continued 12- and 24-month after the initial time of combination chemotherapy.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
14atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 16 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2014 Prognostic factors influencing survival in 35 patients with malignant peritoneal mesotheliomaAtıf 63 · OpenAlex
- 2014 Prognostic factors influencing survival in 35 patients with malignant peritoneal mesotheliomaAtıf 63 · OpenAlex
- 2014 Prognostic factors influencing survival in 35 patients with malignant peritoneal mesotheliomaAtıf 63 · OpenAlex
- 2014 Prognostic Factors Influencing Survival in 35 patients with Malignant Peritoneal MesotheliomaAtıf 63 · OpenAlex
- 2015 Fibulin-3 as a Diagnostic Biomarker in Patients with Malignant MesotheliomaAtıf 37 · OpenAlex
- 2015 Fibulin 3 as a Diagnostic Biomarker in Patients with Malignant MesotheliomaAtıf 37 · OpenAlex
- 2015 Fibulin 3 as a Diagnostic Biomarker in Patients with Malignant MesotheliomaAtıf 37 · OpenAlex
- 2015 Fibulin 3 as a Diagnostic Biomarker in Patients with Malignant MesotheliomaAtıf 37 · OpenAlex
- 2014 Relationship Between Prognosis and Neutrophil Lymphocyte and Platelet Lymphocyte Ratios in Patients with Malignant Pleural MesotheliomasAtıf 26 · OpenAlex
- 2015 Prognostic factors in malignant pleural mesothelioma A retrospective study of 60 Turkish patientsAtıf 13 · OpenAlex